Severe Preeclampsia: Clinical Trials

3 trials for Severe Preeclampsia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 terminated, 1 unknown. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Not yet recruiting 1, Terminated 1, Unknown 1
Phase 21Terminated 1

Follow Severe Preeclampsia: new trials by email Literature Review of Severe Preeclampsia trials Research Report on Severe Preeclampsia

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure
Levetiracetam, magnesium sulfate - Severe Preeclampsia, Eclampsia Preeclampsia
Phase 3Not yet recruitingNebraska Methodist Health System12402026-01-012025-10-24
Study of the Efficacy and Safety of AMAG-423 (Digoxin Immune Fab) in Antepartum Subjects With Severe Preeclampsia
AMAG-423 (digoxin immune fab), Placebo - Severe Preeclampsia
Phase 2 / Phase 3TerminatedAMAG Pharmaceuticals, Inc.582017-04-122026-05-22
Carbetocin vs. Oxytocin for Prevention of Postpartum Bleeding in Patients With Severe Preeclampsia
Carbetocin, Oxytocin - Severe Preeclampsia, Postpartum Hemorrhage
Phase 3UnknownSaint Thomas Hospital, Panama6362012-01-012015-01-05

Narrower conditions

Pre-Eclampsia (3)  ·  Eclampsia (1)  ·  Postpartum Hemorrhage (1)  ·  Seizures (1)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (3)  ·  Hypertension, Pregnancy-Induced (3)  ·  Pregnancy Complications (3)  ·  Urogenital Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Hemorrhage (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Obstetric Labor Complications (1)  ·  Pathologic Processes (1)  ·  Puerperal Disorders (1)  ·  Signs and Symptoms (1)  ·  Uterine Hemorrhage (1)

Interventions

Levetiracetam (1)  ·  Magnesium Sulfate (1)  ·  Oxytocin (1)  ·  carbetocin (1)  ·  digoxin antibodies Fab fragments (1)

Sponsors

AMAG Pharmaceuticals, Inc. (1)  ·  Nebraska Methodist Health System (1)  ·  Saint Thomas Hospital, Panama (1)

Countries

United States (2)  ·  Panama (1)  ·  Poland (1)  ·  South Africa (1)

Top investigators

Osvaldo A Reyes, MD (1)  ·  Todd Lovgren, MD (1)